Rivaroxaban versus nadroparin for thromboprophylaxis following thoracic surgery for lung cancer: A randomized, noninferiority trial

Mengmeng Zhao(Tongji University), Chang Chen(Shanghai Pulmonary Hospital), Chao Jiang(Tongji University), Qiankun Chen(Beijing Tongren Hospital), Lei Shen(Tongji University), Jiaqi Li(Tongji University), Xiaogang Liu(Tongji University), Yang Yang(Tongji University), Jian Li(Sichuan University), Lisha Xu(Tongji University), Yunlang She(Tongji University), Yi Bao(Tongji University), Linsong Chen(Tongji University), Gening Jiang(Tongji University)
American Journal of Hematology
May 4, 2023
Cited by 15


Related Papers